IP Library Granted Patent US 7,601,820
Granted Patent B2
US 7,601,820 · App. 11/353,597 · Granted Oct 13, 2009

Preparation of alkyl-substituted 2-deoxy-2-fluoro-D-ribofuranosyl pyrimidines and purines and their derivatives

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,601,820
App. No.
11/353,597
Granted
Oct 13, 2009
Kind
B2
Abstract

The present invention provides (i) a process for preparing a 2-deoxy-2-fluoro-2-methyl-D-ribonolactone derivative, (ii) conversion of the lactone to nucleosides with potent anti-HCV activity, and their analogues, and (iii) a method to prepare the anti-HCV nucleosides containing the 2-deoxy-2-fluoro-2-C-methyl-β-D-ribofuranosyl nucleosides from a preformed, preferably naturally-occurring, nucleoside.

Claims (27)

1. A compound of the following formula:

wherein R 3 and R 5 can be independently H, CH 3 , benzyl, 4-methoxybenzyl, trityl, trialkylsilyl, t-butyldialkylsilyl, t-butyldiphenylsilyl, tetraisopropyldisilyl (TIPDS), tetrahydropyranyl (THP), methoxymethyl (MOM), β-methoxyethoxymethyl (MEM), or acyl;

alternatively, R 3 and R 5 are linked through —SiR 2 —O—SiR 2 — or —SiR 2 —, wherein R is a lower alkyl.

2. A compound of claim 1 , wherein R 3 and R 5 are each independently H, CH 3 , acetyl, benzoyl, pivaloyl, 4-nitrobenzoyl, 3-nitrobenzoyl, 2-nitrobenzoyl, 4-chlorobenzoyl, 3-chlorobenzoyl, 2-chlorobenzoyl, 4-methylbenzoyl, 3-methylbenzoyl, 2-methylbenzoyl, 4-phenylbenzoyl, benzyl, 4-methoxybenzyl, trityl, trialkylsilyl, t-butyl-dialkylsilyl, t-butyldiphenylsilyl, TIPDS, THP, MOM, or MEM.

3. A compound of claim 1 , wherein R 3 and R 5 are each independently H, CH 3 , acetyl, benzoyl, benzyl, trityl, trialkylsilyl, t-butyl-dialkylsilyl, t-butyldiphenylsilyl, TIPDS, THP, MOM, or MEM.

4. A compound of claim 1 , wherein R 3 and R 5 are each independently H, CH 3 , acetyl, benzyl, trityl, trialkylsilyl, t-butyl-dialkylsilyl, t-butyldiphenylsilyl, TIPDS, or THP.

5. A compound of claim 1 , wherein R 3 and R 5 are each independently H, CH 3 , acetyl, benzyl, trityl, trialkylsilyl, t-butyl-dialkylsilyl, t-butyldiphenylsilyl, or TIPDS.

6. A compound of claim 1 , wherein R 3 and R 5 are each independently H, CH 3 , acetyl, benzyl, trialkylsilyl, t-butyl-dialkylsilyl, t-butyldiphenylsilyl, or TIPDS.

7. A compound of claim 1 , wherein R 3 and R 5 are each independently H, CH 3 , acetyl, or benzyl.

8. A compound of claim 1 , wherein R 3 and R 5 are each independently H, CH 3 , or acetyl.

9. A compound of claim 1 , wherein R 3 and R 5 are each independently H or CH 3 .

10. A compound of claim 1 , wherein R 3 and R 5 are H.

11. A compound of claim 1 , wherein R 3 and R 5 are CH 3 .

12. A compound of claim 1 , wherein R 3 and R 5 are acetyl.

13. A compound of claim 1 , wherein R 3 and R 5 are benzyl.

14. A compound of claim 1 , wherein R 3 and R 5 are acyl.

15. A compound of claim 1 , wherein R 3 and R 5 are linked through —SiR 2 —O—SiR 2 — or —SiR 2 —, and

wherein R is selected from among methyl, ethyl, n-propyl, and i-propyl.

16. A process for the preparation of the compound of claim 1 wherein R 5 is H and R 3 is Bz, comprising the steps of:

(a) reacting a compound of the formula, 39,

with an alkyl-2-bromopropionate in the presence of activated zinc in a solvent;

(b) adding an oxidizing agent to provide a ketone;

(c) fluorinating the product of step (b) to produce a fluorinated ketone;

(d) reducing the fluorinated ketone of step (c); and

(e) benzylating the product of step (d).

17. The process of claim 16 , wherein the solvent of step (a) is selected from the group consisting of diethyl ether and tetrahydrofuran.

18. The process of claim 16 , wherein the oxidizing agent of step (b) is selected from the group consisting of: an activated dimethylsulfoxide, a chromatic agent, a Dess-Martin periodione, and tetrapropylammonium perruthenate.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2022
From: GILEAD PHARMASSET LLC
To: GILEAD SCIENCES, INC.
Reel/Frame 058776/0127 →
CHANGE OF NAME Recorded Jul 19, 2013
From: PHARMASSET, INC.
To: GILEAD PHARMASSET LLC
Reel/Frame 030843/0272 →
CHANGE OF NAME Recorded Mar 23, 2012
From: PHARMASSET, INC.
To: GILEAD PHARMASSET LLC
Reel/Frame 027921/0559 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2006
From: WANG, PEIYUAN; STEC, WOJCIECH; CHUN, BYOUNG-KWON; SHI, JUNXING; DU, JINFA
To: PHARMASSET INC.
Reel/Frame 017671/0139 →